Narcolepsy Explained

A chronic neurological disorder in which the brain cannot keep sleep and wakefulness apart.

Narcolepsy is a chronic neurological disorder of sleep-wake control. Its defining symptom is excessive daytime sleepiness that persists however much a person sleeps at night. Type 1 includes cataplexy, brief muscle weakness set off by emotion and follows the loss of brain cells that make hypocretin; type 2 has no cataplexy, and its cause is less clear.1,2 Diagnosis takes an overnight sleep study and a next-day nap test, and treatment centers on wake-promoting medication.3,4

What Happens in the Brain

Healthy sleep runs in distinct states. Wakefulness holds steady through the day. REM sleep, the dreaming stage when the muscles go slack, stays confined to the night. In narcolepsy those boundaries leak. Fragments of REM sleep break into waking hours, and wakefulness breaks into the night.5

In type 1 the cause is known. People with the disorder have lost 85% to 95% of the neurons in the hypothalamus that make hypocretin, also called orexin, a chemical messenger that keeps wakefulness stable.2 The loss is thought to be autoimmune, although that has not been shown directly.5 In type 2, hypocretin levels are usually normal and the mechanism is not yet understood.1

The Five Core Symptoms

Sleepiness is present in everyone with narcolepsy. Cataplexy occurs only in type 1, and the other three vary from person to person.5,6

Excessive daytime sleepiness. A steady background drowsiness broken by sleep that is hard or impossible to resist: in a meeting, over a meal, at a red light. A short nap often clears it, for a while.1

Cataplexy. Sudden, brief loss of muscle control triggered by strong emotion, most often laughter. It can be as slight as a sagging jaw or as complete as a fall, and awareness stays intact throughout.5

Sleep paralysis. Seconds to minutes of being unable to move or speak while falling asleep or waking up.6

Hallucinations at the edges of sleep. Vivid images, sounds or a sense of presence, real enough to be mistaken for events.6

Broken nighttime sleep. Frequent waking at night, despite the sleepiness during the day.6

Type 1 and Type 2

Type 1

Defined by cataplexy, by low hypocretin in the spinal fluid, or both.1

Type 2

The same sleepiness and the same nap-test findings, without cataplexy or low hypocretin.1 It is the more commonly diagnosed form: US data from 2023 found type 2 more than three times as prevalent as type 1.7 A type 2 diagnosis can change, because cataplexy that appears later moves it to type 1.1 Type 2 also shares ground with idiopathic hypersomnia, a separate disorder with similar sleepiness but without early REM sleep on testing.1

How Narcolepsy Is Diagnosed

Narcolepsy is confirmed by testing, not by symptoms. A questionnaire such as the Epworth Sleepiness Scale shows how sleepy someone is, but it cannot identify the cause.1 The standard work-up follows a fixed sequence.3

Two weeks of preparation. A sleep diary or a wrist activity monitor documents at least six hours of sleep a night, so the test measures the disorder rather than ordinary sleep loss. Stimulants and REM-suppressing medications, including many antidepressants, are usually stopped at least two weeks beforehand, under a clinician’s direction.3

An overnight sleep study. Polysomnography records brain waves, breathing and movement, and rules out other causes of sleepiness such as sleep apnea.3

A daytime nap test. The multiple sleep latency test offers five nap opportunities across the following day. Falling asleep in eight minutes or less on average, with REM sleep in at least two naps, supports the diagnosis; REM sleep early in the previous night can count as one of the two.3

Why Diagnosis Takes Years

Studies report average delays of up to 15 years between first symptoms and diagnosis.8 Sleepiness is easy to put down to lifestyle, and the other symptoms are often missed or attributed to something else.8

How Narcolepsy Is Treated

There is no cure, and no current treatment slows the disorder; treatment aims to control symptoms.5

Scheduled sleep. Fixed sleep times plus short, planned naps reduced unscheduled daytime sleep in a controlled comparison, mainly in people who stayed very sleepy despite medication.9

Medication. The American Academy of Sleep Medicine’s 2021 guideline strongly recommends four medications for adults with narcolepsy: modafinil, pitolisant, sodium oxybate and solriamfetol. It conditionally recommends armodafinil, dextroamphetamine and methylphenidate.4 The right choice depends on which symptoms dominate. Cataplexy needs a medication that acts on it, such as sodium oxybate or pitolisant.4

Modafinil. Approved by the FDA in 1998 to improve wakefulness in adults with excessive sleepiness associated with narcolepsy, modafinil is a prescription medication taken once a day in the morning.10 In the two nine-week trials behind its approval, clinicians rated 58% to 72% of patients taking it as improved, against 37% to 38% on placebo,10 and a 2026 meta-analysis of the randomized trials confirmed reductions in both measured and self-reported sleepiness.11

It treats the sleepiness, not the cataplexy: a pooled analysis of nine trials found no effect on cataplexy attacks.12 Headache is its most common side effect; modafinil side effects and safety covers the full profile, including rare serious rashes and interactions with hormonal birth control.10

Getting Evaluated

If you have never been tested, the first step is an overnight sleep study and nap test, arranged through a sleep medicine specialist. That testing takes place in a sleep lab and cannot be done by telehealth.3

If you already have a documented diagnosis of narcolepsy without cataplexy, a telehealth evaluation can review your history and decide whether treatment is appropriate. Bring your sleep study and nap-test reports and a list of current medications. Not every evaluation ends in a prescription.

New cataplexy, or symptoms that have changed since diagnosis, belong with a sleep specialist or neurologist.

Sources

  1. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed, text revision. American Academy of Sleep Medicine; 2023. https://aasm.org/clinical-resources/international-classification-sleep-disorders/
  2. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469-474. doi:10.1016/S0896-6273(00)00058-1 https://doi.org/10.1016/S0896-6273(00)00058-1
  3. Krahn LE, Arand DL, Avidan AY, et al. Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine. J Clin Sleep Med. 2021;17(12):2489-2498. doi:10.5664/jcsm.9620 https://doi.org/10.5664/jcsm.9620
  4. Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(9):1881-1893. doi:10.5664/jcsm.9328 https://doi.org/10.5664/jcsm.9328
  5. Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100. doi:10.1038/nrdp.2016.100 https://doi.org/10.1038/nrdp.2016.100
  6. Bassetti CLA, Adamantidis A, Burdakov D, et al. Narcolepsy: clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15(9):519-539. doi:10.1038/s41582-019-0226-9 https://doi.org/10.1038/s41582-019-0226-9
  7. Ghosh S, Hoffman V, Calingaert B, et al. The prevalence and incidence of narcolepsy in the United States: a real-world observational study using a validated narcolepsy case definition. Sleep Adv. 2026;7(2):zpag043. doi:10.1093/sleepadvances/zpag043 https://doi.org/10.1093/sleepadvances/zpag043
  8. Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15(5):502-507. doi:10.1016/j.sleep.2014.01.015 https://doi.org/10.1016/j.sleep.2014.01.015
  9. Rogers AE, Aldrich MS, Lin X. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep. 2001;24(4):385-391. doi:10.1093/sleep/24.4.385 https://doi.org/10.1093/sleep/24.4.385
  10. Provigil (modafinil) tablets, C-IV. Prescribing information. Cephalon, LLC. DailyMed. Accessed October 5, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e16c26ad-7bc2-d155-3a5d-da83ad6492c8
  11. Mann GS, Ramakrishnan M, Pakkam ML, Sufiyan N, Kukadiya R, Girigosavi KB. An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy. Sleep Med X. 2026;11:100185. doi:10.1016/j.sleepx.2026.100185 https://doi.org/10.1016/j.sleepx.2026.100185
  12. Golicki D, Bala MM, Niewada M, Wierzbicka A. Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit. 2010;16(8):RA177-RA186. https://medscimonit.com/abstract/index/idArt/881094